z-logo
open-access-imgOpen Access
Ist die Ergänzung der Basistherapie mit tiefdosiertem Prednisolon bei älteren Patienten mit rheumatoider Arthritis vertretbar? Resultate der randomisiert-kontrollierten GLORIA-Studie
Author(s) -
Carina Mihai
Publication year - 2022
Publication title -
kompass autoimmun
Language(s) - German
Resource type - Journals
eISSN - 2624-8476
pISSN - 2624-8468
DOI - 10.1159/000525970
Subject(s) - medicine , rheumatoid arthritis , prednisolone , discontinuation , adverse effect , placebo , gastroenterology , pathology , alternative medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom